share_log

Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Boyle Kevin S. Sr.

Alaunos Therapeutics | 4:持股變動聲明-首席執行官 Boyle Kevin S. Sr.

SEC announcement ·  2023/09/05 17:34
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息